about
Detection approaches for multidrug resistance genes of leukemia.IDH1 R132H mutation regulates glioma chemosensitivity through Nrf2 pathway.Chemosensitizing indomethacin-conjugated dextran-based micelles for effective delivery of paclitaxel in resistant breast cancer therapy.Integrated proteomic and N-glycoproteomic analyses of doxorubicin sensitive and resistant ovarian cancer cells reveal glycoprotein alteration in protein abundance and glycosylation.MicroRNA-340-5p modulates cisplatin resistance by targeting LPAATβ in osteosarcoma.The role of long noncoding RNA HOTAIR in the acquired multidrug resistance to imatinib in chronic myeloid leukemia cells.The Role of CD44 and ERM Proteins in Expression and Functionality of P-glycoprotein in Breast Cancer Cells.MicroRNA-134 reverses multidrug resistance in human lung adenocarcinoma cells by targeting FOXM1LncRNA plasmacytoma variant translocation 1 is an oncogene in bladder urothelial carcinoma.Proteins regulating the intercellular transfer and function of P-glycoprotein in multidrug-resistant cancer.Pantoprazole Induces Apoptosis of Leukemic Cells by Inhibiting Expression of P-Glycoprotein/Multidrug Resistance-Associated Protein-1 Through PI3K/AKT/mTOR Signaling.Ginger Phytochemicals Inhibit Cell Growth and Modulate Drug Resistance Factors in Docetaxel Resistant Prostate Cancer Cell.Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells.A novel mechanism governing the transcriptional regulation of ABC transporters in MDR cancer cells.Roles of Extracellular Vesicles in Metastatic Breast Cancer.S100A9 regulates cisplatin chemosensitivity of squamous cervical cancer cells and related mechanism
P2860
Q33596508-EE2BCAE5-F5A7-4FCA-9270-D53B2B57456BQ33709922-0E669A43-544B-46C6-B26A-3F3F13661DEBQ33883851-8671A28E-D9BC-4D97-86AE-AF3ACF73917BQ37706632-33FBF585-457D-4D34-BAEA-3192FFB1707DQ38706022-25F943D0-732A-485B-81A7-B1E954E81702Q38729618-30C82CE3-DC2C-4E96-BDD1-A90BE7B87A98Q38789245-11FF7D79-7DF6-4946-8521-C04413B78FAEQ38814178-F0793606-6284-4F17-A48A-6121F22DC38CQ41899411-2E28F77D-81C1-4740-8BD0-B1009B3E8373Q47110047-4642AD42-C572-4AB6-839A-5BCF26E87FDCQ47597731-32525834-33E6-4856-9152-C0C1232D846EQ47855461-0DE39AA7-83A2-456F-AED7-F0F1DD565FB1Q49888021-BDC9EB31-D694-4F52-9ED4-32B6D81CF303Q51219257-3293D4CF-0771-4F55-B13F-15C6FE9D23D3Q55035055-44C501A4-9B6B-4BEE-A39D-A40547E7CCBAQ57071692-ACCAFBC4-236F-4B1B-837C-1C4DC6334BE3
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
MRP1 and its role in anticancer drug resistance.
@en
type
label
MRP1 and its role in anticancer drug resistance.
@en
prefLabel
MRP1 and its role in anticancer drug resistance.
@en
P2093
P2860
P1476
MRP1 and its role in anticancer drug resistance.
@en
P2093
Deep Pokharel
Jamie F Lu
Mary Bebawy
P2860
P304
P356
10.3109/03602532.2015.1105253
P407
P577
2015-11-05T00:00:00Z